Analysis Report: Lupin Ltd (BUY; Estimated Price: Rs.2740)

About the Company

Lupin Ltd was founded by Dr Desh Bandhu Gupta in 1968 with a vision and dream to fight life threatening infectious diseases and to manufacture drugs of the highest social priority. Itis dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies. Lupin is the 7^th largest pharmaceutical company globally by market capitalization and 10^th largest pharmaceutical company globally by sales.

Analysis Report: Aurobindo Pharma (BUY; Estimated Price: Rs.1076)

About the Company

Aurobindo Pharma Limited is a public pharmaceutical manufacturing organization headquartered in Hyderabad, India. The company fabricates generic pharmaceuticals and active pharmaceutical ingredients. It was established in 1986 by Mr. P. V. Ramaprasad Reddy and Mr. K. Nityananda Reddy. The company initiated operations in 1988-89 with a single unit producing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995.

Analysis Report: TATA ELXSI (BUY; Estimated Price: Rs. 3172)

About the Company

Tata Elxsi founded in 1989 is a design company that blends technology, creativity and engineering to help customers transform ideas into world-class products and solutions.

A part of the $100 billion Tata group, it addresses the communications, consumer products, defence, healthcare, media & entertainment, semiconductor and transportation sectors. This is supported by a network of design studios, development centres and offices worldwide.